301015 Qingdao Baheal Medical INC.
- 32.40
- -0.66-2.00%
Qingdao Baheal Medical INC. News
Qingdao Baheal Medical INC.: Announcement on the adjustment of Baiyang debt-for-equity conversion price
Qingdao Baheal Medical INC.: 2023 Equity Distribution Implementation Notice
Qingdao Baheal Medical INC.: Announcement of Resolutions of the 19th Meeting of the Third Board of Directors
Qingdao Baheal Medical INC.: Shanghai Baiyang Pharmaceutical Co., Ltd. Asset Assessment Report
Qingdao Baheal Medical INC.: Qingdao Baiyang Yiren Investment Management Co., Ltd. Asset Evaluation Report
Qingdao Baheal Medical INC.: Qingdao Baiyang Investment Group Co., Ltd. Asset Evaluation Report
Qingdao Baheal Medical INC.: Shanghai Baiyang Pharmaceutical Co., Ltd. Audit Report
Qingdao Baheal Medical INC.: Qingdao Baiyang Investment Group Co., Ltd. Audit Report
Qingdao Baheal Medical INC.: Dongxing Securities Co., Ltd. inspection opinions on the acquisition of shares and related transactions of Shanghai Baiyang Pharmaceutical Co., Ltd., Qingdao Baiyang Investment Group Co., Ltd., Qingdao Baiyang Yiren Investment Management Co., Ltd., and Beijing Baiyang Kanghe Technology Co., Ltd.
Qingdao Baheal Medical INC.: Announcement on the acquisition of shares and related transactions of Shanghai Baiyang Pharmaceutical Co., Ltd., Qingdao Baiyang Investment Group Co., Ltd., Qingdao Baiyang Yiren Investment Management Co., Ltd., and Beijing Baiyang Kanghe Technology Co., Ltd.
Qingdao Baheal Medical INC.: Audit Report of Qingdao Baiyang Yiren Investment Management Co., Ltd.
Qingdao Baheal Medical INC.: Announcement of Resolutions of the 16th Meeting of the Third Board of Supervisors
Qingdao Baheal Medical INC.: Beijing Baiyang Kanghe Technology Co., Ltd. Audit Report
Qingdao Baheal Medical INC.: Beijing Baiyang Kanghe Technology Co., Ltd. Asset Evaluation Report
Qingdao Baheal Medical INC.: Announcement on the suspension of share conversion of Baiyang Convertible Bonds during the 2023 equity distribution period
Qingdao Baheal Medical INC.: May 15, 2024 Investor Relations Activity Schedule
Qingdao Baheal Medical INC.: Legal Opinions of Beijing Tianyuan Law Firm on the 2023 Annual General Meeting of Shareholders of Qingdao Baiyang Pharmaceutical Co., Ltd.
Qingdao Baheal Medical INC.: Dongxing Securities Co., Ltd.'s verification opinion on Qingdao Baiyang Pharmaceutical Co., Ltd. increasing the estimated amount of daily related transactions to purchase products from related parties in 2024
Qingdao Baheal Medical INC.: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Qingdao Baheal Medical INC.: Announcement on increasing the estimated amount of daily related transactions to purchase products from related parties in 2024
Analysis
Price Target
No Data
